Risultati per 'Covance':
Di seguito l'elenco dei risultati di ricerca trovati rilevanti per la keyword 'Covance':
Risultati maggiormente rilevanti:
covance | labcorp
BURLINGTON, N.C. -- (BUSINESS WIRE)--May 28, 2020-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that Covance, its drug development business, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials, often referred to as ...
investigator portalInvestigator Portal
labcorp drug development - wikipediaLabcorp Drug Development is a contract research organization headquartered in Burlington, North Carolina, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology industries. Formerly called Covance, the company is part of Labcorp, which employs more than 70,000 people worldwide.. Labcorp Drug Development offers services in the preclinical ...
Altri risultati:
covance clinical trialsCovance Clinical Trials
lab r&d testing for biopharma companies | labcorpWe are a laboratory powerhouse. With labs for nonclincial studies and clinical trial testing strategically located around the globe, we have the ability to scale quickly and efficiently, performing more than 15,000 research studies and processing more than 4.4 million clinical trial testing kits annually.
contact us | covance - labcorp drug developmentThe Americas. +1.888.COVANCE. (+1.888.268.2623) +1.609.452.4440. Asia/Pacific. +1.800.6568.3000. +65.6.5686588. If you have questions regarding open job positions or internships, please visit the careers site. If you are an investigator and have questions, please refer to your Lab Manual or visit the investigators site.
labcorp and covance launch extensive preclinical, clinical and post ...With more than 20 years of experience in delivering development solutions for advanced therapies, such as cell and gene therapy products, Covance provides a unique offering of specialized expertise and coordinated capabilities, combined with focused investments supporting the preclinical, clinical and post-approval phases of development.